All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

An expert panel hosted by

The Lymphoma Hub logo and the Multiple Myeloma Hub logo

Sequencing immune-based therapies in B-cell malignancies

with Ulric Jäger, Sagar Lonial, and Krina Patel

Saturday, June 15 | 18:00-19:30 CEST

Register now

This independent education activity is sponsored by Bristol Myers Squibb. All content is developed independently by the faculty. Funders are allowed no direct influence on the content of this activity.


The Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
You're logged in! Click here any time to manage your account or log out.
You're logged in! Click here any time to manage your account or log out.

Talking to your patients with Waldenstrom Macroglobulinemia

Apr 6, 2023
Learning objective: After reading this article, learners will be able to recall key recommendations for talking to patients with Waldenstrom Macroglobulinemia.

Waldenstrom’s Macroglobulinemia (WM) is a rare hematological malignancy and many healthcare professionals (HCPs) may only treat a handful of patients with the condition throughout their careers. There is a lack of education about the disease and its treatment in patients with WM. Therefore, HCPs treating patients with WM face challenges in communicating key information about the disease and treatment options to patients.

The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) developed a reference guide to assist communication between HCPs and patients with WM to address this unmet need. As part of our ongoing partnership with the IWMF, the Lymphoma Hub is happy to present a concise quick reference guide to assist time-pressed HCPs treating patients with WM.

For more from the IWMF click here.

Visual abstract

To download this visual abstract, click below.

Download here

Waldenstrom's Macroglobulinemia Essential Information: A Physician's Guide

To download this, click below.

Download here

Understanding your specialty helps us to deliver the most relevant and engaging content.

Please spare a moment to share yours.

Please select or type your specialty

  Thank you


Subscribe to get the best content related to lymphoma & CLL delivered to your inbox